Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism
NCT ID: NCT01721811
Last Updated: 2015-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Function in Relation to Long Term Changes in the Glucose Level
NCT00973401
The Retinal Function in Relation to Glucose Changes
NCT00973726
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
NCT02326259
Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
NCT00403195
Hippocampal Metabolism and Function in Patients With Type 1 Diabetes
NCT01852968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy study participanats
Hyperoxia
Glucose
Diabetes
Patients with diabetes
Hyperoxia
Glucose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperoxia
Glucose
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No known systemic or ocular disease.
* Diabetes mellitus
* No intraocular disease other than conditions attributable to diabetes.
Exclusion Criteria
Patients with diabetes
* Intraocular disease other than conditions attributable to diabetes.
* Systemic conditions which might contraindicate hyperoxic stimulation.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oliver Niels Klefter
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Klefter, MD
Role: PRINCIPAL_INVESTIGATOR
Glostrup UH
Michael Larsen, Professor, DMSci
Role: STUDY_DIRECTOR
Glostrup UH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Glostrup University Hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Oliver Klefter, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Oliver Klefter, MD
Role: primary
Michael Larsen, Professor, DMSci
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Klefter2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.